-- Medpace (MEDP) reported Q1 earnings late Wednesday of $4.28 per diluted share, up from $3.67 a year earlier.
Analysts surveyed by FactSet expected $3.92.
Revenue for the three months ended March 31 was $706.6 million, up from $558.6 million a year earlier.
Analysts polled by FactSet expected $697.6 million.
For 2026, the company expects EPS of $16.68 to $17.50 on revenue of $2.76 billion to $2.86 billion. Analysts expect EPS of $17.16 on revenue of $2.81 billion.
The company said Jesse Geiger notified his intention to resign as president and that he will retire effective May 31. CEO August Troendle will reassume the role of president until a successor is appointed, the company added.